Melina Hoffmann

Melina Hoffmann is a skilled professional in the biomedical field with extensive experience in research and investment. Currently an Associate at Syncona Limited since January 2025, Melina previously served as an Investment Fellow at BGV (BioGeneration Ventures) and held the position of Head of Discovery at Valink Therapeutics. Academic roots include a PhD student and researcher role at King's College London, alongside postdoctoral research at The Institute of Cancer Research. Melina's research experience spans positions at various institutions, including research assistant roles at An Najah National University, the University of Costa Rica, and McGill University, focusing on antibacterial activity, organic synthesis, and cytotoxicity assays. Melina holds a Master of Science in biomedical and translational science research from King's College London and a Bachelor of Science in Life Science from the University of Konstanz.